UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Use of Liver Imaging and Biopsy in Clinical Practice

The New England journal of medicine, 2017-08, Vol.377 (8), p.756-768

2017

Volltextzugriff (PDF)

Hepatitis B cure: From discovery to regulatory approval

Hepatology (Baltimore, Md.), 2017-10, Vol.66 (4), p.1296-1313

2017

Volltextzugriff (PDF)

Hepatitis B cure: From discovery to regulatory approval

Journal of hepatology, 2017-10, Vol.67 (4), p.847-861

2017

Volltextzugriff (PDF)

Chronic hepatitis B

Hepatology (Baltimore, Md.), 2007-02, Vol.45 (2), p.507-539

2007

Volltextzugriff (PDF)

Management of patients with hepatitis B who require immunosuppressive therapy

Nature reviews. Gastroenterology & hepatology, 2014-04, Vol.11 (4), p.209-219

2014

Volltextzugriff (PDF)

Utility of Liquid Biopsy Analysis in Detection of Hepatocellular Carcinoma, Determination of Prognosis, and Disease Monitoring: A Systematic Review

Clinical gastroenterology and hepatology, 2020-12, Vol.18 (13), p.2879-2902.e9

2020

Volltextzugriff (PDF)

Appropriate and Potentially Inappropriate Medication Use in Decompensated Cirrhosis

Hepatology (Baltimore, Md.), 2021-06, Vol.73 (6), p.2429-2440

2021

Volltextzugriff (PDF)

A risk score to predict the development of hepatic encephalopathy in a population‐based cohort of patients with cirrhosis

Hepatology (Baltimore, Md.), 2018-10, Vol.68 (4), p.1498-1507

2018

Volltextzugriff (PDF)

Hepatitis C virus reactivation in patients receiving cancer treatment: A prospective observational study

Hepatology (Baltimore, Md.), 2018-01, Vol.67 (1), p.36-47

2018

Volltextzugriff (PDF)

Present and future therapies of hepatitis B: From discovery to cure

Hepatology (Baltimore, Md.), 2015-12, Vol.62 (6), p.1893-1908

2015

Volltextzugriff (PDF)

Microbiome therapeutics for hepatic encephalopathy

Journal of hepatology, 2021-12, Vol.75 (6), p.1452-1464

2021

Volltextzugriff (PDF)

Outcome of sustained virological responders with histologically advanced chronic hepatitis C

Hepatology (Baltimore, Md.), 2010-09, Vol.52 (3), p.833-844

2010

Volltextzugriff (PDF)

International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma

Gastroenterology (New York, N.Y. 1943), 2021-06, Vol.160 (7), p.2572-2584

2021

Volltextzugriff (PDF)

Primary Care Physician Perspectives on Hepatitis C Management in the Era of Direct-Acting Antiviral Therapy

Digestive diseases and sciences, 2016-12, Vol.61 (12), p.3460-3468

2016

Volltextzugriff (PDF)

Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection

The New England journal of medicine, 2014-01, Vol.370 (3), p.211-221

2014

Volltextzugriff (PDF)

Understanding the Natural History of Hepatitis B Virus Infection and the New Definitions of Cure and the Endpoints of Clinical Trials

Clinics in liver disease, 2019-08, Vol.23 (3), p.401-416

2019

Volltextzugriff (PDF)

DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort

Journal of hepatology, 2020-09, Vol.73 (3), p.540-548

2020

Volltextzugriff (PDF)

Systematic review: radiomics for the diagnosis and prognosis of hepatocellular carcinoma

Alimentary pharmacology & therapeutics, 2021-10, Vol.54 (7), p.890-901

2021

Volltextzugriff (PDF)

Incidence of Hepatitis B Virus Reactivation and Hepatotoxicity in Patients Receiving Long-term Treatment With Tumor Necrosis Factor Antagonists

Clinical gastroenterology and hepatology, 2018-12, Vol.16 (12), p.1964-1973.e1

2018

Volltextzugriff (PDF)

Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1

The New England journal of medicine, 2012-01, Vol.366 (3), p.216-224

2012

Volltextzugriff (PDF)

The high burden of alcoholic cirrhosis in privately insured persons in the United States

Hepatology (Baltimore, Md.), 2018-09, Vol.68 (3), p.872-882

2018

Volltextzugriff (PDF)

Functional cure of hepatitis B requires silencing covalently closed circular and integrated hepatitis B virus DNA

The Journal of clinical investigation, 2022-09, Vol.132 (18)

2022

Volltextzugriff (PDF)

Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice

Hepatology (Baltimore, Md.), 2011-06, Vol.53 (6), p.1854-1863

2011

Volltextzugriff (PDF)

Interferon Treatment for Hepatitis B

Clinics in liver disease, 2016-11, Vol.20 (4), p.645-665

2016

Volltextzugriff (PDF)

Public health impact of antiviral therapy for hepatitis C in the United States

Hepatology (Baltimore, Md.), 2009-12, Vol.50 (6), p.1750-1755

2009

Volltextzugriff (PDF)

1 – 25 von 1.429

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.008)
Mit Volltextzugriff
(1.263)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(737)
Life Sciences & Biomedicine
(714)
Humans
(569)
Gastroenterology & Hepatology
(505)
Female
(310)
Male
(302)
Middle Aged
(245)
Adult
(236)
Infectious Diseases
(185)
Biological And Medical Sciences
(174)
Medical Sciences
(164)
Antiviral Agents - Therapeutic Use
(156)
Aged
(123)
Hepatitis B
(122)
Viral Hepatitis
(113)
Viral Diseases
(110)
Human Viral Diseases
(107)
Hepatology
(102)
Hepatitis B Virus - Genetics
(100)
Hepatitis
(99)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Use of Liver Imaging and Biopsy in Clinical Practice

Hepatitis B cure: From discovery to regulatory approval

Hepatitis B cure: From discovery to regulatory approval

Chronic hepatitis B

Management of patients with hepatitis B who require immunosuppressive therapy

Utility of Liquid Biopsy Analysis in Detection of Hepatocellular Carcinoma, Determination of Prognosis, and Disease Monitoring: A Systematic Review

Appropriate and Potentially Inappropriate Medication Use in Decompensated Cirrhosis

A risk score to predict the development of hepatic encephalopathy in a population‐based cohort of patients with cirrhosis

Hepatitis C virus reactivation in patients receiving cancer treatment: A prospective observational study

Present and future therapies of hepatitis B: From discovery to cure

Microbiome therapeutics for hepatic encephalopathy

Outcome of sustained virological responders with histologically advanced chronic hepatitis C

International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma

Primary Care Physician Perspectives on Hepatitis C Management in the Era of Direct-Acting Antiviral Therapy

Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection

Understanding the Natural History of Hepatitis B Virus Infection and the New Definitions of Cure and the Endpoints of Clinical Trials

DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort

Systematic review: radiomics for the diagnosis and prognosis of hepatocellular carcinoma

Incidence of Hepatitis B Virus Reactivation and Hepatotoxicity in Patients Receiving Long-term Treatment With Tumor Necrosis Factor Antagonists

Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1

The high burden of alcoholic cirrhosis in privately insured persons in the United States

Functional cure of hepatitis B requires silencing covalently closed circular and integrated hepatitis B virus DNA

Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice

Interferon Treatment for Hepatitis B

Public health impact of antiviral therapy for hepatitis C in the United States

Suchergebnisse filtern